PPARγ Agonist Pioglitazone Reverses Memory Impairment and Biochemical Changes in a Mouse Model of Type 2 Diabetes Mellitus

Aims: Pioglitazone, known as a peroxisome proliferator‐activated receptor γ (PPARγ) agonist, is used to treat type 2 diabetes mellitus (T2DM). T2DM has been associated with reduced performance on numerous domains of cognitive function. Here, we investigated the effects of pioglitazone on memory impa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:CNS Neurosci Ther
Autors principals: Jiang, Li‐Ying, Tang, Su‐Su, Wang, Xiao‐Yun, Liu, Li‐Ping, Long, Yan, Hu, Mei, Liao, Ming‐Xing, Ding, Qi‐Long, Hu, Wei, Li, Jia‐Chang, Hong, Hao
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2012
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493499/
https://ncbi.nlm.nih.gov/pubmed/22620268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2012.00341.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars